Synapse

← The EPMA Journal

Papers in The EPMA Journal

Page 7 · newest first

  1. Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction?The EPMA Journal · 2011
  2. Biomarker development for non-invasive prenatal diagnosis of fetal aneuploidies: predictive reliability and potential clinical applicationThe EPMA Journal · 2011
  3. Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosisThe EPMA Journal · 2011
  4. Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differencesThe EPMA Journal · 2011
  5. Genetic testing: predictive value of genotyping for diagnosis and management of diseaseThe EPMA Journal · 2011
  6. Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseasesThe EPMA Journal · 2011
  7. Clinical implications of the causal relationship between insomnia and depression: how individually tailored treatment of sleeping difficulties could prevent the onset of depressionThe EPMA Journal · 2011
  8. Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity?The EPMA Journal · 2011
  9. A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approachesThe EPMA Journal · 2011
  10. Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway – implications for the prevention of cardiovascular diseases in societies with rapid economic developmentThe EPMA Journal · 2011
  11. Obstructive sleep apnea: its prevention and screening may contribute to the prevention of hypertension, diabetes and cardiovascular diseasesThe EPMA Journal · 2011
  12. Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseasesThe EPMA Journal · 2011
  13. Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatmentsThe EPMA Journal · 2011
  14. Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular riskThe EPMA Journal · 2011
  15. Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?The EPMA Journal · 2011
  16. Personalized cardiac regeneration by stem cells–Hype or hope?The EPMA Journal · 2011
  17. Why we need integrative medicineThe EPMA Journal · 2011
  18. The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular diseaseThe EPMA Journal · 2011
  19. Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?The EPMA Journal · 2011
  20. Taiwan’s healthcare report 2010The EPMA Journal · 2010
  21. The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicineThe EPMA Journal · 2010
  22. The German healthcare systemThe EPMA Journal · 2010
  23. Economic concerns about global healthcare in lung, head and neck cancer: meeting the economic challenge of predictive, preventive and personalized medicineThe EPMA Journal · 2010
  24. Health promotion and work: prevention of shift work disorders in companiesThe EPMA Journal · 2010
  25. Healthcare in Serbia in transition periodThe EPMA Journal · 2010
  26. Overview of healthcare in the UKThe EPMA Journal · 2010
  27. Healthcare in overview of TurkeyThe EPMA Journal · 2010
  28. Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?The EPMA Journal · 2010
  29. Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?The EPMA Journal · 2010
  30. Moving from correlative science to predictive oncologyThe EPMA Journal · 2010
  31. Non-invasive proteomics—thinking about personalized breast cancer screening and treatmentThe EPMA Journal · 2010
  32. The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomasThe EPMA Journal · 2010
  33. Selenium in the prevention of human cancersThe EPMA Journal · 2010
  34. Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and controlThe EPMA Journal · 2010
  35. Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancerThe EPMA Journal · 2010
  36. Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapyThe EPMA Journal · 2010
  37. New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatmentThe EPMA Journal · 2010
  38. Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical applicationThe EPMA Journal · 2010
  39. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costsThe EPMA Journal · 2010
  40. Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?The EPMA Journal · 2010
  41. Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapiesThe EPMA Journal · 2010
  42. Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacyThe EPMA Journal · 2010
  43. Multiple sclerosis pharmacogenetics: personalized approach towards tailored therapeuticsThe EPMA Journal · 2010
  44. Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practiceThe EPMA Journal · 2010
  45. Retinal vein occlusions: The potential impact of a dysregulation of the retinal veinsThe EPMA Journal · 2010
  46. Targeted preventive measures and advanced approaches in personalised treatment of glaucoma neuropathyThe EPMA Journal · 2010
  47. Alzheimer’s disease: diagnostics, prognostics and the road to preventionThe EPMA Journal · 2010
  48. Predictive, preventive and personalised medicine for age-related macular degenerationThe EPMA Journal · 2010
  49. Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicineThe EPMA Journal · 2010
  50. Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficitsThe EPMA Journal · 2010